nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—DDR2—uterine cervix—vaginal cancer	0.0209	0.0209	CbGeAlD
Regorafenib—DDR2—endometrium—vaginal cancer	0.0189	0.0189	CbGeAlD
Regorafenib—DDR2—mammalian vulva—vaginal cancer	0.0182	0.0182	CbGeAlD
Regorafenib—FRK—female reproductive system—vaginal cancer	0.0174	0.0174	CbGeAlD
Regorafenib—DDR2—uterus—vaginal cancer	0.0174	0.0174	CbGeAlD
Regorafenib—DDR2—female reproductive system—vaginal cancer	0.0156	0.0156	CbGeAlD
Regorafenib—MAPK11—female reproductive system—vaginal cancer	0.0148	0.0148	CbGeAlD
Regorafenib—DDR2—female gonad—vaginal cancer	0.0142	0.0142	CbGeAlD
Regorafenib—DDR2—vagina—vaginal cancer	0.0141	0.0141	CbGeAlD
Regorafenib—MAPK11—female gonad—vaginal cancer	0.0135	0.0135	CbGeAlD
Regorafenib—BRAF—endometrium—vaginal cancer	0.0133	0.0133	CbGeAlD
Regorafenib—EPHX2—urethra—vaginal cancer	0.0129	0.0129	CbGeAlD
Regorafenib—FLT4—epithelium—vaginal cancer	0.0128	0.0128	CbGeAlD
Regorafenib—FGFR1—uterine cervix—vaginal cancer	0.0125	0.0125	CbGeAlD
Regorafenib—EPHX2—mammalian vulva—vaginal cancer	0.0123	0.0123	CbGeAlD
Regorafenib—BRAF—uterus—vaginal cancer	0.0123	0.0123	CbGeAlD
Regorafenib—EPHX2—uterus—vaginal cancer	0.0117	0.0117	CbGeAlD
Regorafenib—FGFR1—urethra—vaginal cancer	0.0115	0.0115	CbGeAlD
Regorafenib—RET—epithelium—vaginal cancer	0.0113	0.0113	CbGeAlD
Regorafenib—FGFR1—mammalian vulva—vaginal cancer	0.011	0.011	CbGeAlD
Regorafenib—FGFR2—epithelium—vaginal cancer	0.0107	0.0107	CbGeAlD
Regorafenib—FGFR2—uterine cervix—vaginal cancer	0.0107	0.0107	CbGeAlD
Regorafenib—EPHA2—epithelium—vaginal cancer	0.0106	0.0106	CbGeAlD
Regorafenib—EPHA2—uterine cervix—vaginal cancer	0.0105	0.0105	CbGeAlD
Regorafenib—FGFR1—uterus—vaginal cancer	0.0104	0.0104	CbGeAlD
Regorafenib—TEK—epithelium—vaginal cancer	0.0103	0.0103	CbGeAlD
Regorafenib—BRAF—female gonad—vaginal cancer	0.01	0.01	CbGeAlD
Regorafenib—BRAF—vagina—vaginal cancer	0.00999	0.00999	CbGeAlD
Regorafenib—FLT1—epithelium—vaginal cancer	0.00996	0.00996	CbGeAlD
Regorafenib—RAF1—epithelium—vaginal cancer	0.00991	0.00991	CbGeAlD
Regorafenib—FLT1—uterine cervix—vaginal cancer	0.00988	0.00988	CbGeAlD
Regorafenib—RAF1—uterine cervix—vaginal cancer	0.00982	0.00982	CbGeAlD
Regorafenib—EPHA2—urethra—vaginal cancer	0.00963	0.00963	CbGeAlD
Regorafenib—EPHX2—female gonad—vaginal cancer	0.0096	0.0096	CbGeAlD
Regorafenib—EPHX2—vagina—vaginal cancer	0.00955	0.00955	CbGeAlD
Regorafenib—FLT4—female reproductive system—vaginal cancer	0.00952	0.00952	CbGeAlD
Regorafenib—EPHA2—endometrium—vaginal cancer	0.00947	0.00947	CbGeAlD
Regorafenib—TEK—urethra—vaginal cancer	0.00939	0.00939	CbGeAlD
Regorafenib—TEK—endometrium—vaginal cancer	0.00924	0.00924	CbGeAlD
Regorafenib—EPHA2—mammalian vulva—vaginal cancer	0.00916	0.00916	CbGeAlD
Regorafenib—FLT1—urethra—vaginal cancer	0.00908	0.00908	CbGeAlD
Regorafenib—RAF1—urethra—vaginal cancer	0.00903	0.00903	CbGeAlD
Regorafenib—FLT1—endometrium—vaginal cancer	0.00893	0.00893	CbGeAlD
Regorafenib—RAF1—endometrium—vaginal cancer	0.00888	0.00888	CbGeAlD
Regorafenib—FGFR2—uterus—vaginal cancer	0.00888	0.00888	CbGeAlD
Regorafenib—FLT4—female gonad—vaginal cancer	0.00866	0.00866	CbGeAlD
Regorafenib—FLT1—mammalian vulva—vaginal cancer	0.00864	0.00864	CbGeAlD
Regorafenib—RAF1—mammalian vulva—vaginal cancer	0.00859	0.00859	CbGeAlD
Regorafenib—FGFR1—female gonad—vaginal cancer	0.00855	0.00855	CbGeAlD
Regorafenib—TEK—uterus—vaginal cancer	0.00852	0.00852	CbGeAlD
Regorafenib—FGFR1—vagina—vaginal cancer	0.00849	0.00849	CbGeAlD
Regorafenib—KDR—epithelium—vaginal cancer	0.00842	0.00842	CbGeAlD
Regorafenib—KDR—uterine cervix—vaginal cancer	0.00835	0.00835	CbGeAlD
Regorafenib—FLT1—uterus—vaginal cancer	0.00823	0.00823	CbGeAlD
Regorafenib—RAF1—uterus—vaginal cancer	0.00819	0.00819	CbGeAlD
Regorafenib—FGFR2—female reproductive system—vaginal cancer	0.00799	0.00799	CbGeAlD
Regorafenib—EPHA2—female reproductive system—vaginal cancer	0.00785	0.00785	CbGeAlD
Regorafenib—PDGFRA—uterus—vaginal cancer	0.00772	0.00772	CbGeAlD
Regorafenib—KDR—urethra—vaginal cancer	0.00767	0.00767	CbGeAlD
Regorafenib—TEK—female reproductive system—vaginal cancer	0.00766	0.00766	CbGeAlD
Regorafenib—KDR—endometrium—vaginal cancer	0.00755	0.00755	CbGeAlD
Regorafenib—KIT—epithelium—vaginal cancer	0.00746	0.00746	CbGeAlD
Regorafenib—FLT1—female reproductive system—vaginal cancer	0.0074	0.0074	CbGeAlD
Regorafenib—KIT—uterine cervix—vaginal cancer	0.0074	0.0074	CbGeAlD
Regorafenib—RAF1—female reproductive system—vaginal cancer	0.00736	0.00736	CbGeAlD
Regorafenib—KDR—mammalian vulva—vaginal cancer	0.00731	0.00731	CbGeAlD
Regorafenib—PDGFRB—epithelium—vaginal cancer	0.00729	0.00729	CbGeAlD
Regorafenib—FGFR2—female gonad—vaginal cancer	0.00727	0.00727	CbGeAlD
Regorafenib—PDGFRB—uterine cervix—vaginal cancer	0.00723	0.00723	CbGeAlD
Regorafenib—EPHA2—female gonad—vaginal cancer	0.00714	0.00714	CbGeAlD
Regorafenib—EPHA2—vagina—vaginal cancer	0.0071	0.0071	CbGeAlD
Regorafenib—TEK—female gonad—vaginal cancer	0.00697	0.00697	CbGeAlD
Regorafenib—KDR—uterus—vaginal cancer	0.00696	0.00696	CbGeAlD
Regorafenib—PDGFRA—female reproductive system—vaginal cancer	0.00694	0.00694	CbGeAlD
Regorafenib—KIT—urethra—vaginal cancer	0.0068	0.0068	CbGeAlD
Regorafenib—FLT1—female gonad—vaginal cancer	0.00674	0.00674	CbGeAlD
Regorafenib—RAF1—female gonad—vaginal cancer	0.0067	0.0067	CbGeAlD
Regorafenib—FLT1—vagina—vaginal cancer	0.00669	0.00669	CbGeAlD
Regorafenib—KIT—endometrium—vaginal cancer	0.00669	0.00669	CbGeAlD
Regorafenib—RAF1—vagina—vaginal cancer	0.00666	0.00666	CbGeAlD
Regorafenib—PDGFRB—urethra—vaginal cancer	0.00664	0.00664	CbGeAlD
Regorafenib—PDGFRB—endometrium—vaginal cancer	0.00654	0.00654	CbGeAlD
Regorafenib—KIT—mammalian vulva—vaginal cancer	0.00647	0.00647	CbGeAlD
Regorafenib—ABL1—uterine cervix—vaginal cancer	0.00644	0.00644	CbGeAlD
Regorafenib—PDGFRB—mammalian vulva—vaginal cancer	0.00632	0.00632	CbGeAlD
Regorafenib—PDGFRA—female gonad—vaginal cancer	0.00631	0.00631	CbGeAlD
Regorafenib—PDGFRA—vagina—vaginal cancer	0.00627	0.00627	CbGeAlD
Regorafenib—KDR—female reproductive system—vaginal cancer	0.00626	0.00626	CbGeAlD
Regorafenib—KIT—uterus—vaginal cancer	0.00617	0.00617	CbGeAlD
Regorafenib—PDGFRB—uterus—vaginal cancer	0.00602	0.00602	CbGeAlD
Regorafenib—ABL1—urethra—vaginal cancer	0.00592	0.00592	CbGeAlD
Regorafenib—ABL1—endometrium—vaginal cancer	0.00583	0.00583	CbGeAlD
Regorafenib—KDR—female gonad—vaginal cancer	0.00569	0.00569	CbGeAlD
Regorafenib—KDR—vagina—vaginal cancer	0.00566	0.00566	CbGeAlD
Regorafenib—ABL1—mammalian vulva—vaginal cancer	0.00564	0.00564	CbGeAlD
Regorafenib—KIT—female reproductive system—vaginal cancer	0.00554	0.00554	CbGeAlD
Regorafenib—PDGFRB—female reproductive system—vaginal cancer	0.00542	0.00542	CbGeAlD
Regorafenib—ABL1—uterus—vaginal cancer	0.00537	0.00537	CbGeAlD
Regorafenib—KIT—female gonad—vaginal cancer	0.00505	0.00505	CbGeAlD
Regorafenib—KIT—vagina—vaginal cancer	0.00501	0.00501	CbGeAlD
Regorafenib—PDGFRB—female gonad—vaginal cancer	0.00493	0.00493	CbGeAlD
Regorafenib—PDGFRB—vagina—vaginal cancer	0.0049	0.0049	CbGeAlD
Regorafenib—ABL1—female reproductive system—vaginal cancer	0.00483	0.00483	CbGeAlD
Regorafenib—ABL1—female gonad—vaginal cancer	0.00439	0.00439	CbGeAlD
Regorafenib—ABL1—vagina—vaginal cancer	0.00437	0.00437	CbGeAlD
Regorafenib—ABCG2—uterine cervix—vaginal cancer	0.00406	0.00406	CbGeAlD
Regorafenib—CYP2C8—endometrium—vaginal cancer	0.00378	0.00378	CbGeAlD
Regorafenib—ABCG2—urethra—vaginal cancer	0.00373	0.00373	CbGeAlD
Regorafenib—ABCG2—endometrium—vaginal cancer	0.00367	0.00367	CbGeAlD
Regorafenib—ABCG2—mammalian vulva—vaginal cancer	0.00355	0.00355	CbGeAlD
Regorafenib—ABCG2—uterus—vaginal cancer	0.00339	0.00339	CbGeAlD
Regorafenib—CYP2C19—vagina—vaginal cancer	0.00324	0.00324	CbGeAlD
Regorafenib—CYP2C8—female reproductive system—vaginal cancer	0.00313	0.00313	CbGeAlD
Regorafenib—CYP2C8—vagina—vaginal cancer	0.00283	0.00283	CbGeAlD
Regorafenib—CYP2B6—female reproductive system—vaginal cancer	0.00281	0.00281	CbGeAlD
Regorafenib—CYP2C9—female reproductive system—vaginal cancer	0.00278	0.00278	CbGeAlD
Regorafenib—ABCG2—female gonad—vaginal cancer	0.00277	0.00277	CbGeAlD
Regorafenib—ABCG2—vagina—vaginal cancer	0.00275	0.00275	CbGeAlD
Regorafenib—CYP2B6—vagina—vaginal cancer	0.00254	0.00254	CbGeAlD
Regorafenib—CYP3A4—female reproductive system—vaginal cancer	0.00212	0.00212	CbGeAlD
Regorafenib—ABCB1—epithelium—vaginal cancer	0.00202	0.00202	CbGeAlD
Regorafenib—ABCB1—uterine cervix—vaginal cancer	0.002	0.002	CbGeAlD
Regorafenib—ABCB1—urethra—vaginal cancer	0.00184	0.00184	CbGeAlD
Regorafenib—ABCB1—endometrium—vaginal cancer	0.00181	0.00181	CbGeAlD
Regorafenib—ABCB1—mammalian vulva—vaginal cancer	0.00175	0.00175	CbGeAlD
Regorafenib—ABCB1—uterus—vaginal cancer	0.00167	0.00167	CbGeAlD
Regorafenib—ABCB1—female reproductive system—vaginal cancer	0.0015	0.0015	CbGeAlD
Regorafenib—ABCB1—female gonad—vaginal cancer	0.00137	0.00137	CbGeAlD
Regorafenib—ABCB1—vagina—vaginal cancer	0.00136	0.00136	CbGeAlD
